Latest Breaking News On - Company or mindmed - Page 5 : comparemela.com

Mind Medicine Inc: MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress

Mind Medicine Inc: MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaMaxim jacobsRobert barrowCompany quarterly report on formCompany annual report on formCompany or mindmedExchange commissionMedicine mindmed incCompany phaseCorporate communicationsChief executive officerAnnual reportQuarterly reportNote regarding forward looking statementsFinancial conditionMedia investor inquiries

MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress

– Preclinical data in ASD model demonstrate the differences between MM-402 , S-MDMA and Racemic MDMA with enhanced pro-social effects and reduced hyperactivity – .

Comunidad autonoma de catalunaRobert barrowMedicine mindmed incCompany quarterly report on formCompany annual report on formCompany phaseCompany or mindmedExchange commissionMind medicineChief executive officerAnnual reportQuarterly reportNote regarding forward looking statementsFinancial condition

MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)

– 198 participants dosed across 20 clinical sites – – On track for topline results in Q4 2023 – .

Robert barrowMedicine mindmed incCompany annual report on formCompany or mindmedExchange commissionCompany phaseCompany quarterly report on formMind medicineChief executive officerHamilton anxiety rating scaleAnnual reportQuarterly reportNote regarding forward looking statementsFinancial condition

Mind Medicine (MindMed) Inc : MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)

Mind Medicine (MindMed) Inc : MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergRobert barrowMaxim jacobsCompany annual report on formMedicine mindmed incCompany or mindmedExchange commissionCorporate communicationsCompany quarterly report on formCompany phaseChief executive officerHamilton anxiety rating scaleAnnual reportQuarterly reportNote regarding forward looking statementsFinancial condition

MindMed to Participate at September Investor Conferences

MindMed to Participate at September Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maxim jacobsCompany or mindmedCorporate communicationsMedicine mindmed incFireside chatAnnual global investmentInvestor presentationCantor global healthcareInvestor resourcesInvestor inquiriesInvestor relationsMind medicine